Company intelligence / Profile preview

Prolacta Bioscience

Duarte, California, United Statesprolacta.com ↗

Ownership: Private
Employees: ~310
Development stage: Commercial

Overview

Prolacta's 100% human milk–based nutritional products have been evaluated in more than 20 clinical studies published in peer-reviewed journals, demonstrating improved health outcomes such as reduced rates of necrotizing enterocolitis when used as part of an exclusive human milk diet for premature infants. Over 100,000 premature infants worldwide have benefited from their products to date.[1][2][3]

Therapeutic areas: OtherGastroenterologyRare Diseases
Modalities: Human milk-based nutritional products
Industry: Non-Drug Biotech

Drug pipeline

2 assets

Prolact+ H2MF

Commercial

Indications: Premature infant nutrition, Necrotizing enterocolitis prevention

1 more asset in the full pipeline.

Request access →

Partnerships

Health Evolution PartnersFrontier Venture CapitalAlta PartnersEW Healthcare PartnersAisling Capital

Beyond the preview

Go deeper on Prolacta Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prolacta Bioscience.

Explore the full profile